Share ownership Novo Nordisk A/S

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2025-11-14 am EST			5-day change	1st Jan Change
311.05 ^DKK	-2.39%		+6.82%	-50.17%

08:14pm	Some Wall St hedge funds trimmed megacap positions in 3rd quarter	RE
Nov. 14	Sector Update: Health Care Stocks Ease Late Afternoon	MT

Share class: Novo Nordisk A/S

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	10	1,075,000,000	0	0	70.25 %
Stock B	1	3,390,000,000	3,136,564,503 ( 92.52 %)	24,000,000 ( 0.708 %)

Major shareholders: Novo Nordisk A/S

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 5.238 %	177,560,500	5.238 %	8 761 M kr
NOVO NORDISK A/S 0.7654 %	25,947,151	0.7654 %	1 280 M kr
Nordea Investment Management AB 0.1348 %	4,571,494	0.1348 %	226 M kr
State Street Global Advisors Ltd. 0.1344 %	4,557,571	0.1344 %	225 M kr
ODIN Forvaltning AS 0.1338 %	4,536,454	0.1338 %	224 M kr
Sjunde AP-fonden 0.1328 %	4,502,464	0.1328 %	222 M kr
Nykredit Bank A/S (Investment Management) 0.1212 %	4,109,671	0.1212 %	203 M kr
Capfi Delen Asset Management NV 0.1088 %	3,689,205	0.1088 %	182 M kr
ACATIS Investment Kapitalverwaltungsgesellschaft mbH 0.0943 %	3,195,938	0.0943 %	158 M kr
Eurizon Capital SGR SpA 0.0772 %	2,616,675	0.0772 %	129 M kr
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Bank of America Merrill Lynch Banco Multiplo SA 0.001518 %	411,620	0.001518 %	3 M kr
Western Asset Management Company DTVM Ltda. 0.001032 %	279,842	0.001032 %	2 M kr
Caixa DTVM SA 0.000007 %	1,870	0.000007 %	11 705 kr

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 100 %	1,074,872,000	100 %	53 036 M kr
ANIMA Sgr SpA 0.0108 %	115,783	0.0108 %	6 M kr
Russell Investments Ltd. 0.002186 %	23,492	0.002186 %	1 M kr

Name	Equities	%	Valuation
Capital Research & Management Co. (International Investors) 0.5225 %	17,713,424	0.5225 %	876 M kr
Loomis, Sayles & Co. LP 0.4768 %	16,165,468	0.4768 %	800 M kr
Merrill Lynch International 0.4342 %	14,721,478	0.4342 %	728 M kr
Eaton Vance Management 0.4214 %	14,284,790	0.4214 %	707 M kr
Fidelity Management & Research Co. LLC 0.4152 %	14,075,391	0.4152 %	696 M kr
Fiduciary Trust Company International 0.4125 %	13,984,789	0.4125 %	692 M kr
Fayez Sarofim & Co. LLC 0.3098 %	10,503,662	0.3098 %	520 M kr
Fisher Asset Management LLC 0.3045 %	10,322,903	0.3045 %	511 M kr
Folketrygdfondet 0.3012 %	10,211,913	0.3012 %	505 M kr
RBC Private Counsel (USA), Inc. 0.2658 %	9,011,895	0.2658 %	446 M kr
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	48.22%
Other	1%
Novo Nordisk A/S	0.77%
State Street Corp.	0.18%
Markel Group, Inc.	0.07%
Individuals	0.01%
SEI Investments Co.	0.01%
Menora Mivtachim Holdings Ltd.	0.01%
Silvercrest Asset Management Group, Inc.	0.01%
Unknown	49.72%

Based on 1000 largest holdings

Geographical origin of shareholders

Denmark	37.94%
United States	7.58%
United Kingdom	1.2%
Norway	0.74%
Canada	0.45%
Sweden	0.39%
Germany	0.33%
Finland	0.19%
Italy	0.16%
Ireland	0.16%
Spain	0.15%
Luxembourg	0.15%
Belgium	0.13%
France	0.13%
Switzerland	0.12%
Netherlands	0.1%
Australia	0.06%
Taiwan	0.06%
Japan	0.02%
Singapore	0.02%
Slovenia	0.02%
Brazil	0.02%
Israel	0.02%
South Africa	0.02%
Austria	0.02%
Portugal	0.01%
Individuals	0.01%
Mexico	0.01%
Hong Kong	0.01%
Liechtenstein	0.01%
New Zealand	0.01%
Puerto Rico	0.01%
Iceland	0.01%

Based on 1000 largest holdings

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (93.6%); - rare disease treatment products (6.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (20.8%), the United States (57.6%), North America (3.7%), China (6.4%) and other (11.5%).

Employees

78,554

Sector

Pharmaceuticals

Calendar

Feb. 04 - Q4 2025 Earnings Release

More about the company